Navigation Links
Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development
Date:12/21/2011

ressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the intended effects of the Board's actions, the ability of synthetic DNA-based biologics to optimize the delivery of therapeutic proteins and provide physicians with a way to transform the way diseases are treated, the opportunity for shareholders resulting from our change in priority, the clinical trials that are expected to continue and the Company's intention to seek marketing partners for reaZin™ and wellZin™. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, the failure of future clinical trials for our products in the emerging field of synthetic DNA-based therapeutics to be successful, our failure to successfully develop and commercialize products in the emerging field of synthetic DNA-based therapeutics, the failure of our new products to be accepted by physicians, the failure of the new products to have their desired results, our inability to find marketing partners for reaZin™ and wellZin™, the failure of the changes approved by the Board of Directors to have their desired results, and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2010 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


'/>"/>
SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
2. Adeona Reports Third Quarter 2011 Financial Results
3. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
4. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
5. Adeona Appoints Jeff Lucero Riley as Independent Chairman
6. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
7. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
8. Adeona Appoints George A. Eby to Scientific Advisory Board
9. Adeona Reports Second Quarter 2011 Financial Results
10. Adeona to Host Second Quarter 2011 Investor Conference Call
11. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... Calif. , July 21, 2014  PowerVision, ... first fluid-based accommodating intraocular lens, today announced that ... Mosbacher, and Law Chair of Ophthalmology, and Professor ... joined the company,s Scientific Advisory Board. ... including the American Academy of Ophthalmology Lifetime Achievement ...
(Date:7/21/2014)... VIEJO, Calif. , July 21, 2014  Avanir ... that the U.S. Food and Drug Administration (FDA) accepted ... Phase II study assessing the safety and efficacy of ... initiate this study evaluating AVP-786 for the adjunctive treatment ... quarter of 2014. "The endorsement of ...
(Date:7/21/2014)... 2014 Integrity Applications, Inc. (OTCQB: IGAP) ... ® model DF-F noninvasive blood glucose measurement ... its wholly-owned subsidiary, Integrity Applications Ltd., into a ... of Acer Inc.  Pursuant to the agreement, Wistron ... non-exclusive basis) the GlucoTrack Model DF-F and any ...
Breaking Medicine Technology:PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 2PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 2Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 3
(Date:7/22/2014)... MonaVie announces today that nutrition and ... (SAB). The addition of Macdonald will help ensure the ... development plans and necessary substantiation for research and development. ... been with the company as its nutrition and fitness ... MonaVie’s RVL and CORE line ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Ocean ... center located in Pompano Beach, Florida, has ... the Joint Commission, an independent not-for-profit organization that ... Accreditation signifies that the quality programs offered at ... standards for safety and performance. Ocean Breeze, which ...
(Date:7/22/2014)... Bramal LED announced that they will be featured ... airing later this year via Discovery Channel. Dates and show ... Bramal LED’s T-10 lamps, which provide over 80,000 hours of ... 70 percent. Bramal LED’s T-10 lamps can be plugged into ... on direct AC voltage, with no need for an electrician. ...
(Date:7/22/2014)... July 22, 2014 Chris Carpenter’s ... course that takes a comprehensive, step-by-step approach to teaching ... marketing venture has just been released to the public, ... the internet marketing world if you’re unable to generate ... lot of people simply give up when they find ...
(Date:7/22/2014)... BlackBox Biometrics, Inc. has launched a new ... advancements including a new high-g accelerometer and ... revision of the already robust Blast Gauge System platform, ... blast events by recording a Service member's exposure to ... overpressure that accompany a blast event can cause serious ...
Breaking Medicine News(10 mins):Health News:MonaVie Adds Nutritionist Mark Macdonald to Its Scientific Advisory Board 2Health News:MonaVie Adds Nutritionist Mark Macdonald to Its Scientific Advisory Board 3Health News:Florida Drug and Alcohol Addiction Treatment Center Receives Joint Commission Seal of Approval 2Health News:Florida Drug and Alcohol Addiction Treatment Center Receives Joint Commission Seal of Approval 3Health News:Bramal LED to be featured in Upcoming Episode of Innovations with Ed Begley, Jr. 2Health News:Info Cash 2.0: Review Of Chris Carpenter’s Online Marketing Training Released 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 3
... Services, Inc. (NYSE: AHS ), the largest healthcare ... conference call to discuss fourth quarter and year end results ... The company expects to issue an earnings news release ... market at approximately 4:00 p.m. Eastern Time. A live webcast ...
... Homeland Security Chairman Bennie G. Thompson (D-MS) and ... Science and Technology, James R. Langevin (D-RI), released ... Ready for Pandemic Influenza." The report examines the ... the event of a pandemic influenza outbreak. It ...
... with Complex Rehab MarketHOUSTON, Jan. 14 Anne Kieschnik, ... experience, has joined Alliance Seating & Mobility ... rehab companies. Kieschnik is an Assistive Technology Professional ... Houston, Texas, for ASM ( www.alliance-seating.com ) and is ...
... effort focuses on genetics and who would benefit from ... research may one day help physicians identify those patients ... from certain treatments. , The discoveries, paving the way ... U.S. health-care system millions while sparing patients the agony ...
... Ken Thorpe and Alan Aviles, President and Chief ... and Hospitals Corporation, spoke to reporters today about ... in the economic stimulus package. President-elect Barack Obama ... investments necessary to ensure America,s medical records are ...
... Action for Children,s First Annual Awards CeremonyWASHINGTON, Jan. ... honored Senators Richard Lugar (R-IN), Christopher Dodd (D-CT), ... and Betty McCollum (D-MN-04) with the first annual ... award recognizes those who have done outstanding work ...
Cached Medicine News:Health News:AMN Healthcare Services to Host 2008 Fourth Quarter & Year End Earnings Conference Call on Thursday, February 26, 2009 2Health News:Report: Nation Not Ready for Pan Flu 2Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 2Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 3Health News:Researchers Zero In on GI Cancers 2Health News:Researchers Zero In on GI Cancers 3Health News:Researchers Zero In on GI Cancers 4Health News:PFCD Experts Cite Health Information Technology as Key Investment for Economic Stimulus 2Health News:Senators Lugar, Dodd, Boxer and Representatives Lee and McCollum Receive GAC Children's Champion Award 2
Open wire loops decrease the chance of interfering with instruments, Designed to retract the eyelid during ophthalmic microsurgery or minor office procedures...
For rotating nucleus during phacoemulsification, Also useful for dislocating the nucleus into the anterior chamber during extracapsular cataract extraction, 45, Blunt, Forked, 9.0mm from end...
... drape has two perforations which ... to various single or bilateral ... Refractive drape has two perforations ... adapts to various single or ...
Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
Medicine Products: